Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vaginal Neoplasms × Observation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 11 Stomach Neoplasms 10 Prostatic Neoplasms 10 Neoplasms 10 Endometrial Neoplasms 9 Breast Neoplasms 9 Pancreatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Oropharyngeal Neoplasms 5 Neoplasm Metastasis 5 Multiple Myeloma 5 Mouth Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Lung Neoplasms 5 Carcinoma, Hepatocellular 5 Sarcoma 4 Recurrence 4 Esophageal Neoplasms 4 Colonic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Melanoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Gastrointestinal Stromal Tumors 3 Gallbladder Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Venous Thromboembolism 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Salivary Gland Neoplasms 2 Rectal Neoplasms 2

Interventions

Radiotherapy 7 Brachytherapy 6 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Radiosurgery 3 Methods 3 tremelimumab 2 durvalumab 2 Topotecan 2 Radiation 2 Palliative Care 2 Paclitaxel 2 Gemcitabine 2 Early Intervention, Educational 2 Dehydroepiandrosterone 2 Capecitabine 2 Bevacizumab 2 Behavior Therapy 2 zimberelimab 1 temsirolimus 1 talazoparib 1 liposomal doxorubicin 1 fludarabine phosphate 1 dostarlimab 1 belzutifan 1 alovudine 1 aldesleukin 1 X-Rays 1 Vinorelbine 1 Vaginal Smears 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06514235 2025-08-19

EMBRAVE

Erasmus Medical Center

Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡